Answer in brief
CVE-2026-56402 records a Medium severity (CVSS 6.5) vulnerability in NanoClaw < 2.1.17 - Privilege Escalation via Unverified Approval Response Handler. The current sources do not mark it as known exploited. The current feed maps nanocoai/nanoclaw (generic). Check affected ranges and fixed versions before updating.
Analysis pending evidence review
HOL Guard separates source facts from reviewed analysis. See the methodology.
CVSS is 6.5. The current sources do not mark it as known exploited. Treat this as a source-backed prioritization signal, not a statement about your environment.
Analysis status
Analysis pending evidence review
Factual feed record only; HOL analysis is not approved for indexing. Read the methodology.
The current feed maps nanocoai/nanoclaw (generic). Check affected ranges and fixed versions before updating.
| Package | Affected range | Fixed version |
|---|---|---|
| nanocoai/nanoclawgeneric | >=0 <2.1.17 | 2.1.17 |
Published upstream
Jun 23, 2026
Evidence: source:cvelist:source_dates:source-dates:recordSource modified
Sep 17, 2026
Evidence: source:cvelist:source_dates:source-dates:recordFirst seen by HOL
Jun 23, 2026
NanoClaw before 2.1.17 contains a privilege escalation vulnerability in the handleApprovalsResponse function that fails to verify responder role authorization. Attackers with a valid questionId can approve or reject privileged actions like package installation by submitting approval response payloads without proper role validation.
Quoted source text, attributed separately from HOL analysis.